Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial].

Saved in:
Bibliographic Details
Title: Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial].
Authors: Schmidt, I.1 (AUTHOR), Vergeer, R. A.2 (AUTHOR) ra.vergeer@umcg.nl, Postma, M. R.3 (AUTHOR), van den Berg, G.3 (AUTHOR), Sterkenburg, A. J.1 (AUTHOR), Korsten-Meijer, A. G. W.4 (AUTHOR), Feijen, R. A.4 (AUTHOR), Kruijff, S.5 (AUTHOR), van Beek, A. P.3 (AUTHOR), den Dunnen, W. F. A.6 (AUTHOR), Robinson, D. J.7 (AUTHOR), van Dijk, J. M. C.2 (AUTHOR), Nagengast, W. B.1 (AUTHOR), Kuijlen, J. M. A.2 (AUTHOR)
Source: European Journal of Nuclear Medicine & Molecular Imaging. Jan2025, Vol. 52 Issue 2, p660-668. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first